Registered entities
Auspex Pharmaceuticals, Inc.
Reg. No. 1454189United States
Innovation
209 patent families (44 granted) — focus: Chemistry & metallurgy, Human necessities, Emerging technologies; filing pace slowing. Cited 12,195 times.
| Year | Filings |
|---|---|
| 2015 | 26 |
| 2016 | 32 |
| 2017 | 33 |
| 2018 | 22 |
| 2019 | 14 |
| 2020 | 15 |
| 2021 | 12 |
| 2022 | 13 |
| 2023 | 13 |
| 2024 | 10 |
| 2025 | 9 |
| 2026 | 2 |
Investor mix
7 investors on record; lead investors include Thomas, McNerney & Partners, Panorama Capital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 57% |
| Bank & private debt | 2 | 29% |
| Other / undisclosed | 1 | 14% |